je.st
news
Tag: drug
OPKO Submits Investigational New Drug Application To Initiate A Phase 2a Trial For Its Long-Acting Coagulation Factor VIIa-CTP To Treat Hemophilia
2015-02-04 06:38:34| drugdiscoveryonline Home Page
OPKO Health, Inc. announced the submission of an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) to conduct a Phase 2a study of OPKO's long-acting version of coagulation Factor VIIa (Factor VIIa-CTP) for the treatment of bleeding episodes in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX
Tags: to
application
trial
factor
PsychoGenics Achieves Another Milestone In Drug Discovery Collaboration With Sunovion
2015-02-04 06:21:29| drugdiscoveryonline Home Page
PGI Drug Discovery LLC (PsychoGenics), recently announced the achievement of a milestone in its drug discovery and development collaboration with Sunovion Pharmaceuticals Inc. In August 2007, PsychoGenics and Sunovion entered into a drug discovery and development agreement to combine their complementary strengths and expertise to identify a new generation of treatments for neuropsychiatric disorders
Tags: with
drug
collaboration
discovery
FDA approves Pfizer drug to treat breast cancer in postmenopausal women
2015-02-04 01:08:56| Biotech - Topix.net
U.S. federal health regulators on Tuesday approved a highly anticipated medicine from Pfizer Inc. to treat postmenopausal women with a certain type of advanced breast cancer who have not already taken other drugs. The Food and Drug Administration approved Ibrance for women who have tumors that do not contain a protein known as HER-2.
Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate
2015-02-03 14:17:18| Agriculture - Topix.net
Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.
Tags: trial
drug
phase
patient
Swiss drug maker Novartis posts Q4 profit drop
2015-01-27 10:32:29| Biotech - Topix.net
Swiss pharmaceutical giant Novartis AG says fourth quarter net income dropped 26 percent but the company still posted a healthy 2014 annual profit. The Basel, Switzerland-based company said Tuesday that fourth quarter net income came in at $1.49 billion, down from $2 billion in the same quarter the year before excluding its blood-transfusion diagnostics unit, which it sold in 2013.
Sites : [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] next »